pneumonia- clinical guidelines
TRANSCRIPT
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 1/38
Click to edit Master subtitle style
4/28/12
Clinical Practice Guidelines
In theEvaluation and MANAGEMENTOf PEDIATRIC COMMUNITY ACQUIRED PNEUMONIA
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 2/38
4/28/12
QUICK GUIDE: OBJECTIVE
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 3/38
Click to edit Master subtitle style
4/28/12
What diagnostic aidsare initially requestedfor a patient classified
as either PCAP A or PCAP B beingmanaged in an
ambulatory setting?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 4/38
4/28/12
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 5/38
4/28/12
What diagnostic
aids are initiallyrequested for apatient classified
as either PCAP Cor PCAP D beingmanaged in ahospital setting?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 6/38
4/28/12
Key Recommendation
1. The following should be routinely requested:a. Chest x-ray PA-lateral
b. White blood Cell Count
c. Culture and Sensitivity of i. Blood for PCAP D
ii. Pleural fluid (thoracentesis for pleural effusion)
iii. Tracheal aspirate upon initialintubation
d. Blood gas and/or pulse oximetry (assess gas
exchange)
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 7/38
4/28/12
Key Recommendation
2. The following may be requested:
* Culture and Sensitivity of sputum for
Older children3. The following should not be routinelyrequested: (not shown to demonstrate viral from bacterial
infection)
a. Erythrocyte sedimentation rate
b. C- reactive protein
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 8/38
4/28/12
QUICK GUIDE: OBJECTIVE
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 9/38
4/28/12
When is ANTIBIOTICRECOMMENDED?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 10/38
4/28/12
KEY RECOMMENDATION
1. For a patient classified as either PCAP Aor PCAP B and is
a. beyond 2 years of age ; OR
B. having high grade fever withoutwheeze
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 11/38
4/28/12
rationale
Microbial etiology:
* ≤ 2 y.o.- VIRUSES are most frequentlyimplicated.
As age increases, Bacterial pathogens
(Streptococcus pneumoniae, Mycoplasma
sp and Chlamydia sp) become moreprevalent.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 12/38
4/28/12
rationale
FEATURES BACTERIAL VIRAL
Fever T°= > 38.5 °C T°= < 38.5 °C
Wheeze Absent Present
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 13/38
4/28/12
KEY RECOMMENDATION
2. For a patient classified as PCAP C and is
a. beyond 2 years of age; OR
b. having OR high grade fever withoutwheeze
c. having alveolar consolidation in thechest x-ray; OR
d. having white blood cell count >15000
3. For a patient classified as PCAP D
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 14/38
4/28/12
What empiric treatment
should be administered if abacterial etiology isSTRONGLY considered?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 15/38
4/28/12
Key recommendation
1. For a patient classified asPCAP A or B without
previous antibiotic:
DOC: ORAL AMOXICILLIN 40-50mg/kg/day in 3 divided doses
Alternative: Co-trimoxazole andChloramphenicol palmitate
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 16/38
4/28/12
Oral Amoxicillin
a. Failure rate higher in Co-trimoxazolecompared to Amoxicillin.
b. Failure rate was lower in the Amoxicillingroup compared with chloramphenicol
Amoxicillin vs Azithromycin
Improvement in CXR is greater than 75% in the Azithromycin group vs Amoxicillin
Amoxicillin vs ErythromycinNo difference between amoxicillin and
erythromycin as to cure rate.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 17/38
4/28/12
2. For a patient classified as PCAP C withoutprevious antibiotic and who has completed
the primary immunization againstHaemophilus influenzae type B
DOC: Penicillin G (100,000 U/kg/day) in 4
divided doses
If a primary immunization against H ib has
NOT been completed:DOC: Ampicillin IV (100 mg/kg/day) in 4divided doses should be given
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 18/38
4/28/12
3. For apatient
classified asPCAP D, aspecialist
should beconsulted.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 19/38
4/28/12
2008 Update Highlights:Epedemiology
CAP Common Pathogens:* Streptococcus pneumoniae
*Mycoplasma pneumoniae
*Chlamydia pneumoniae
Pathogen
CA- MRSA (Community Acquired Methicillin
Resistant Staphylococcus aureus
* 93% of MRSA were CA-MRSA
* Hospital Rate MRSA 31%
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 20/38
4/28/12
Antibiotic Resistance (Local Data)
Penicillin ChloramphenicolAmpicillin Co-trimoxazole
S. pneumoniae 6% 5% No data 14%
H. influenzae No data 14% 9% 15%
CA-MRSA- DOC: Vancomycin
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 21/38
4/28/12
Update highlights
For PCAP A and B* There is evidence for the use of Amoxicilin
(45mg/kg/day), 3 divided doses for a minimumduration of 3 days)
* Among patients with known hypersensitivity toamoxicillin, a MACROLIDE antibiotic may beconsidered
* Use of Co-trimoxazole is discouraged because of high failure and resistance rates.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 22/38
4/28/12
Update highlights
For PCAP C
* Equal efficacies were noted between Oralamoxicillin and Parenteral Penicillin among
patients who can tolerate feeding.*Equal efficacies were noted between
monotherapy and Combination therapy for thosewho cannot tolerate feeding.
* For monotherapy --- Parenteral Ampicillin is
the best choice considering the cost.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 23/38
4/28/12
What treatmentshould be initiallygiven if a VIRALetiology isstrongly
considered
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 24/38
4/28/12
Key recommendation
1. Ancillary treatment should only begiven.
2. OSELTAMIVIR (2 mg/kg/dose BID for 5days) or AMANTADINE (4.4- 8.8mg/kg/day for 3-5 days) may be given for influenza that is either confirmed bylaboratory or occurring as an outbreak..
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 25/38
4/28/12
Ancillary Treatments
1. Among inpatients, OXYGEN andHYDRATION should be given if needed.
2. Cough preparations, chest physiotherapy,
bronchial hygiene, nebulization usingNormal Saline Solution, steam inhalation,topical solution, brochodilators and herbalmedicines are not routinely given in
community-acquired pneumonia3. In the presence of WHEEZING, a
bronchodilator may be administered.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 26/38
4/28/12
When can apatient be
considered asresponding tothe currentantibiotic
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 27/38
4/28/12
1. Favorable response: Decrease inRESPIRATORY SIGNS (Tachypnea) and
defervescence within 72 hours after initiationof antibiotic.
2. Reevaluate: Persistence of symptomsbeyond 72 hours after initiation of antibiotics.
3. End of treatment Chest x-ray, WBC, ESR,or CRP should not be done to assesstherapeutic response to antibiotic.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 28/38
4/28/12
What should be
done if a patientis NOTresponding tocurrent antibiotictherapy?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 29/38
4/28/12
Key recommendation
1. If an outpatient classified as either PCAP A or PCAP B is not responding to the currentantibiotic within 72 hours, consider any one of the following:
a. Change the initial antibiotic (Amoxicillin) to:Cefuroxime axetil, Co-Amoxiclav, Sultamicillin,or Cefpodoxime.
b. Start and Oral Macrolide (Mycoplasma/Chlamydia)
c. Reevaluate Diagnosis
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 30/38
4/28/12
Cefuroxime axetil 20-30 mg/kg/day BID x 7days
Co- Amoxiclav 40-50 mg of Amoxicillin/kg/day
BIB x 7 daysSultamicillin 25-50 mg/kg/day, TID/QID x 7days
Cefpodoxime proxetil 20mg/kg/day BID x 7days
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 31/38
4/28/12
3. If an inpatient as PCAP D isnot responding to the current
antibiotic within 72 hours,consider immediate RE-CONSULTATION with a
specialist.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 32/38
4/28/12
Key recommendation
2. If an inpatient classified as PCAP C is notresponding to the current antibiotic within72 hour, consider consultation with aspecialist because of the followingpossibilities:
a. Penicillin resistant Streptococcuspneumoniae; or
b. presence of complications (pulmonary or extrapulmonary);
c. other diagnosis
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 33/38
4/28/12
When canSwitch
therapy in
bacterialpneumonia be
started?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 34/38
4/28/12
Switch from Intravenous antibiotic
administration to oral form 2-3 days after initiation of antibiotic is recommended in apatient who
a. is responding to the initial antibiotictherapy.
b. is able to feed with intact
gastrointestinal absorption; andc. does not have any pulmonary or
extrapulmonary complications..
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 35/38
4/28/12
How can
Pneumonia beprevented?
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 36/38
4/28/12
1. Vaccines recommended by the Philippine
Pediatric Society should be routinelyadministered to prevent pneumonia.
2. Zinc Supplementation (10 mg for infants
and 20 mg for children >20 years of agegiven for a total of 4 – 6 months) may beadministered to prevent pneumonia.
3. Vitamin A, immunomodulators and vitaminC should not be routinely administered as apreventive strategy.
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 37/38
4/28/12
References
1. CPG (Clinical Practice Guidelines In TheEvaluation and Management of PediatricCommunity Acquired Pneumonia)
2. Nelson Textbook of Pediatrics
8/3/2019 Pneumonia- clinical guidelines
http://slidepdf.com/reader/full/pneumonia-clinical-guidelines 38/38
4/28/12
THANK YOU FOR LISTENING!